Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Miles

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Histopathology|April 1, 1996
Adhesion molecule expression and leucocyte trafficking following immunotherapy with recombinant interleukin-2D W Miles, L C Happerfield, L G Bobrow, et al.
Lancet (London, England)|December 7, 1991
Toxicity and reconstitution of recombinant interleukin-2 with albuminD W Miles, S J Longhurst, P G Harper, et al.
British Journal of Cancer|December 1, 1992
Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2D W Miles, D Aderka, H Engelmann, et al.
The Journal of Experimental Medicine|October 30, 2009
THE MODE OF ACTION OF SULFANILAMIDE ON STREPTOCOCCUS. IIF P Gay, A R Clark, J A Street, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 15, 2015
Screening Criteria in Breast Cancer Trials: Are They Too Restrictive?D K Woolf, D W Miles, P D Nathan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Phase II study of docetaxel in patients with liver metastases from breast cancer. UK study groupR E Coleman, A Howell, S P Eggleton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2013
First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: pooled and subgroup analyses of data from 2447 patientsD W Miles, V Diéras, J Cortés, et al.
International Journal of Cancer|January 8, 1998
p53 immunohistochemical staining and survival after adjuvant chemotherapy for breast cancerE A Dublin, D W Miles, R D Rubens, et al.
International Journal of Cancer|July 15, 1999
Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracilD W Miles, W H Harris, C E Gillett, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2001
A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancerD W Miles, I E Smith, R E Coleman, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Histopathology|April 1, 1996
Adhesion molecule expression and leucocyte trafficking following immunotherapy with recombinant interleukin-2D W Miles, L C Happerfield, L G Bobrow, et al.
Lancet (London, England)|December 7, 1991
Toxicity and reconstitution of recombinant interleukin-2 with albuminD W Miles, S J Longhurst, P G Harper, et al.
British Journal of Cancer|December 1, 1992
Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2D W Miles, D Aderka, H Engelmann, et al.
The Journal of Experimental Medicine|October 30, 2009
THE MODE OF ACTION OF SULFANILAMIDE ON STREPTOCOCCUS. IIF P Gay, A R Clark, J A Street, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 15, 2015
Screening Criteria in Breast Cancer Trials: Are They Too Restrictive?D K Woolf, D W Miles, P D Nathan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Phase II study of docetaxel in patients with liver metastases from breast cancer. UK study groupR E Coleman, A Howell, S P Eggleton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2013
First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: pooled and subgroup analyses of data from 2447 patientsD W Miles, V Diéras, J Cortés, et al.
International Journal of Cancer|January 8, 1998
p53 immunohistochemical staining and survival after adjuvant chemotherapy for breast cancerE A Dublin, D W Miles, R D Rubens, et al.
International Journal of Cancer|July 15, 1999
Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracilD W Miles, W H Harris, C E Gillett, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2001
A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancerD W Miles, I E Smith, R E Coleman, et al.
Pageof 8